ロード中...
Growth hormone receptor inhibition decreases the growth and metastasis of pancreatic ductal adenocarcinoma
Pancreatic cancer is the only major cancer with very low survival rates (1%). It is the fourth leading cause of cancer-related death. Hyperactivated growth hormone receptor (GHR) levels have been shown to increase the risk of cancer in general and this pathway is a master regulator of key cellular f...
保存先:
| 出版年: | Exp Mol Med |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Publishing Group
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4221692/ https://ncbi.nlm.nih.gov/pubmed/25301264 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/emm.2014.61 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|